Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, medical device company MAKO Surgical (MAKO +0.00%) has earned a coveted five-star ranking.
With that in mind, let's take a closer look at MAKO and see what CAPS investors are saying about the stock right now.
MAKO facts
|
Headquarters (founded) |
Fort Lauderdale, Fla. (2004) |
|
Market Cap |
$609.5 million |
|
Industry |
Healthcare equipment |
|
Trailing-12-Month Revenue |
$96.2 million |
|
Management |
Chairman/CEO Maurice Ferre CFO Fritz LaPorte |
|
Return on Equity (average, past 3 years) |
(45.8%) |
|
Cash/Debt |
$34.8 million / $0 |
|
Competitors |
Biomet |
Sources: S&P Capital IQ and Motley Fool CAPS.
On CAPS, 97% of the 1,203 members who have rated MAKO believe the stock will outperform the S&P 500 going forward.
Just last week, one of those bulls, fellow Fool David Meier (TMFHumbleServant), tapped MAKO as a tempting long-term turnaround opportunity:
The orthopedic surgery robot maker has had a rough go of it lately. The good thing is that they continue to make progress in attracting larger hospital systems to become customers. That will carry them over the next 5 years.
If you want market-thumping returns, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future.
Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.
